PROCF — Procaps SA Cashflow Statement
0.000.00%
HealthcareSpeculativeMicro Cap
- $2.82m
- $277.55m
- $423.75m
Annual cashflow statement for Procaps SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -17 | -10.4 | -101 | 36.1 | 40.3 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 42.8 | 65.7 | 171 | -8.04 | 30.9 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 26 | -0.846 | -47.8 | -29.4 | 18.2 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 68.3 | 70.9 | 37.3 | 15.6 | 108 |
Capital Expenditures | -19.7 | -17.9 | -24.5 | -34.1 | -32.8 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 7.63 | 0.827 | 0.822 | 1.74 | -1.84 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -12.1 | -17.1 | -23.7 | -32.4 | -34.6 |
Financing Cash Flow Items | -20.9 | -20.9 | 58.4 | -17.5 | -35 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -46.9 | -40.5 | 58 | -12.8 | -97.8 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.802 | 2.19 | 67.9 | -29.1 | -25.5 |